Lipocalin-2 as a Novel Biomarker of Lupus Nephritis
Samy Ibrahim Judah Mohi Eldeen;
Abstract
Lupus nephritis (LN) is a prominent feature in SLE present in 15–30% of patients with lupus at the time of initial diagnosis and 30–50% during disease progression. Present assessment of SLE patients includes a urinalysis, creatinine clearance and measurem
Other data
| Title | Lipocalin-2 as a Novel Biomarker of Lupus Nephritis | Authors | Samy Ibrahim Judah Mohi Eldeen | Keywords | Lipocalin-2 as a Novel Biomarker of Lupus Nephritis | Issue Date | 2009 | Description | Lupus nephritis (LN) is a prominent feature in SLE present in 15–30% of patients with lupus at the time of initial diagnosis and 30–50% during disease progression. Present assessment of SLE patients includes a urinalysis, creatinine clearance and measurem |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.